NG
RMD icon

Novem Group’s ResMed RMD Stock Holding History

Novem Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$962K Buy
4,936
+492
+11% +$102K 0.1% 198
2026
Q1 		$998K Buy
4,444
+241
+6% +$60.1K 0.11% 167
2025
Q4 		$1.01M Buy
4,203
+465
+12% +$119K 0.12% 180
2025
Q3 		$1.02M Buy
3,738
+129
+4% +$35.2K 0.12% 161
2025
Q2 		$931K Sell
3,609
-1,096
-23% -$261K 0.12% 165
2025
Q1 		$1.05M Buy
4,705
+1,152
+32% +$269K 0.15% 126
2024
Q4 		$813K Buy
+3,553
New +$855K 0.12% 156

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Novem Group's RMD Position: Q2 2026 in Review

Novem Group increased its ResMed (RMD) stake by 11% in Q2 2026, buying an estimated $102K and bringing the position to 4,936 shares worth $962K. The position accounts for 0.1% of the portfolio, ranked #198.

Novem Group first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.05M in Q1 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Novem Group held 4,936 shares of ResMed worth $962K as of Q2 2026.
  • Novem Group bought 492 ResMed shares in Q2 2026, an estimated $102K.
  • ResMed made up 0.1% of Novem Group's portfolio in Q2 2026, its #198 holding.
  • Novem Group first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's ResMed position peaked at $1.05M in Q1 2025.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.